These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22382157)

  • 1. Fibrin D-dimer, tissue-type plasminogen activator, von Willebrand factor, and risk of incident stroke in older men.
    Wannamethee SG; Whincup PH; Lennon L; Rumley A; Lowe GD
    Stroke; 2012 May; 43(5):1206-11. PubMed ID: 22382157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of von Willebrand factor, fibrin D-dimer and tissue plasminogen activator with incident coronary heart disease: British Women's Heart and Health cohort study.
    May M; Lawlor DA; Patel R; Rumley A; Lowe G; Ebrahim S
    Eur J Cardiovasc Prev Rehabil; 2007 Oct; 14(5):638-45. PubMed ID: 17925622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
    Lip GY; Lowe GD; Rumley A; Dunn FG
    Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiposity, adipokines, and risk of incident stroke in older men.
    Wannamethee SG; Shaper AG; Whincup PH; Lennon L; Sattar N
    Stroke; 2013 Jan; 44(1):3-8. PubMed ID: 23192755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.
    Wannamethee SG; Sattar N; Rumley A; Whincup PH; Lennon L; Lowe GD
    Diabetes Care; 2008 May; 31(5):995-1000. PubMed ID: 18235054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.
    Roldán V; Marín F; Muiña B; Torregrosa JM; Hernández-Romero D; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2011 Jun; 57(25):2496-504. PubMed ID: 21497043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.
    Pradhan AD; LaCroix AZ; Langer RD; Trevisan M; Lewis CE; Hsia JA; Oberman A; Kotchen JM; Ridker PM
    Circulation; 2004 Jul; 110(3):292-300. PubMed ID: 15238458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study.
    Lowe GD; Yarnell JW; Sweetnam PM; Rumley A; Thomas HF; Elwood PC
    Thromb Haemost; 1998 Jan; 79(1):129-33. PubMed ID: 9459337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study.
    Smith FB; Lee AJ; Fowkes FG; Price JF; Rumley A; Lowe GD
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3321-5. PubMed ID: 9409328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical Activity, Sedentary Behavior, and Inflammatory and Hemostatic Markers in Men.
    Parsons TJ; Sartini C; Welsh P; Sattar N; Ash S; Lennon LT; Wannamethee SG; Lee IM; Whincup PH; Jefferis BJ
    Med Sci Sports Exerc; 2017 Mar; 49(3):459-465. PubMed ID: 28222056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study.
    Smith A; Patterson C; Yarnell J; Rumley A; Ben-Shlomo Y; Lowe G
    Circulation; 2005 Nov; 112(20):3080-7. PubMed ID: 16286603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma d-Dimer and Incident Ischemic Stroke and Coronary Heart Disease: The Atherosclerosis Risk in Communities Study.
    Folsom AR; Gottesman RF; Appiah D; Shahar E; Mosley TH
    Stroke; 2016 Jan; 47(1):18-23. PubMed ID: 26556822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study.
    Smith FB; Lee AJ; Hau CM; Rumley A; Lowe GD; Fowkes FG
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):43-50. PubMed ID: 10691098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy.
    Vene N; Mavri A; Kosmelj K; Stegnar M
    Thromb Haemost; 2003 Dec; 90(6):1163-72. PubMed ID: 14652652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population.
    Rudnicka AR; Rumley A; Lowe GD; Strachan DP
    Circulation; 2007 Feb; 115(8):996-1003. PubMed ID: 17296859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of seasonal patterns in hemostatic factors in older men and their relation to excess winter coronary heart disease deaths.
    Ghebre MA; Wannamethee SG; Rumley A; Whincup PH; Lowe GD; Morris RW
    J Thromb Haemost; 2012 Mar; 10(3):352-8. PubMed ID: 22235876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants.
    Smith FB; Rumley A; Lee AJ; Leng GC; Fowkes FG; Lowe GD
    Br J Haematol; 1998 Mar; 100(4):758-63. PubMed ID: 9531345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-dimer, factor VIII and von Willebrand factor predict a non-dipping pattern of blood pressure in hypertensive patients.
    Agorasti A; Trivellas T; Mourvati E; Papadopoulos V; Tsatalas K; Vargemezis V; Passadakis P
    Int Urol Nephrol; 2013 Jun; 45(3):777-83. PubMed ID: 23001640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.
    Kirmizis D; Tsiandoulas A; Pangalou M; Koutoupa E; Rozi P; Protopappa M; Barboutis K
    Med Sci Monit; 2006 Feb; 12(2):CR55-62. PubMed ID: 16449948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men.
    Wannamethee SG; Lowe GD; Shaper AG; Rumley A; Lennon L; Whincup PH
    Atherosclerosis; 2005 Jul; 181(1):101-8. PubMed ID: 15939060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.